Robert Glanzman - Feb 15, 2022 Form 4 Insider Report for Clene Inc. (CLNN)

Role: Chief Medical Officer
Signature: /s/ Jerry Miraglia POA
Stock symbol: CLNN
Transactions as of: Feb 15, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/16/2022, 08:02 AM
Previous filing: Nov 4, 2021
Next filing: May 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLNN	Stock Options (Right to buy)	Award	$0	+140K		$0.00	140K	Feb 15, 2022	Common Stock	140K	$3.04	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on February 15, 2022 as an option for 140,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $3.04 per share. The options vest with respect to the first 25% of such shares on February 15, 2023 and then in 36 equal installments of the balance of the shares of Common Stock on the 15th day of each calendar month thereafter beginning March 15, 2023 until such shares are fully vested.

Content

This option was granted on February 15, 2022 as an option for 140,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $3.04 per share. The options vest with respect to the first 25% of such shares on February 15, 2023 and then in 36 equal installments of the balance of the shares of Common Stock on the 15th day of each calendar month thereafter beginning March 15, 2023 until such shares are fully vested.